Xeroderma pigmentosum in eastern Turkey: a review of 15 cases
Aim: To determine the demographic and clinical characteristics of xeroderma pigmentosum (XP). XP is a rare autosomal recessive disease that is characterized by cellular hypersensitivity to ultraviolet radiation, development of cancers at an early age, severe actinic changes, and photophobia. Materials and methods: In the dermatology clinic of Yüzüncü Yıl University, Van, Turkey, 15 patients who were diagnosed with XP were seen between April 2004 and May 2010. They were evaluated according to their age, sex, family history, parental relationships, age at onset of skin lesions, presence of cutaneous malignancy, and neurological and ophthalmologic involvement. Results: The patients consisted of 8 males (53.33%) and 7 females (46.67%), and their ages ranged from 4 to 25 years (mean: 12.13). In 2 sibling cases, there was no parental consanguinity. Parental consanguinity was present in all of the other 13 cases (86.67%). The mean age at the onset of skin lesions was 1.4 years. Neurological involvement was not seen in any of the cases, but ophthalmologic involvement was seen in all of the cases. Skin malignancy was detected in 6 patients and actinic keratosis, keratoacanthoma, and multiple ulcers were observed in some of the patients. Conclusion: XP is an inherited disorder and mostly affects the skin. Clinical signs and symptoms usually develop over time. In this series, malignancy developed in 40% of the patients during the follow-up period. This study is a large case series in which XP is clinically assessed.
Xeroderma pigmentosum in eastern Turkey: a review of 15 cases
Aim: To determine the demographic and clinical characteristics of xeroderma pigmentosum (XP). XP is a rare autosomal recessive disease that is characterized by cellular hypersensitivity to ultraviolet radiation, development of cancers at an early age, severe actinic changes, and photophobia. Materials and methods: In the dermatology clinic of Yüzüncü Yıl University, Van, Turkey, 15 patients who were diagnosed with XP were seen between April 2004 and May 2010. They were evaluated according to their age, sex, family history, parental relationships, age at onset of skin lesions, presence of cutaneous malignancy, and neurological and ophthalmologic involvement. Results: The patients consisted of 8 males (53.33%) and 7 females (46.67%), and their ages ranged from 4 to 25 years (mean: 12.13). In 2 sibling cases, there was no parental consanguinity. Parental consanguinity was present in all of the other 13 cases (86.67%). The mean age at the onset of skin lesions was 1.4 years. Neurological involvement was not seen in any of the cases, but ophthalmologic involvement was seen in all of the cases. Skin malignancy was detected in 6 patients and actinic keratosis, keratoacanthoma, and multiple ulcers were observed in some of the patients. Conclusion: XP is an inherited disorder and mostly affects the skin. Clinical signs and symptoms usually develop over time. In this series, malignancy developed in 40% of the patients during the follow-up period. This study is a large case series in which XP is clinically assessed.
___
- Metin A, Akdeniz N. Xeroderma pigmentosum. In: Tüzün Y, Gürer MA, Serdaroğlu S, Oğuz O, Aksungur VL, editors. Dermatology. 3rd ed. İstanbul: Nobel Tıp Kitabevleri; 2008. p.1721-36 (in Turkish).
- Lim HW, Hawk JLM. Photodermatoses. In: Bolognia JL, Jorizzo JL, Rapini RP, editors. Dermatology. 2nd ed. St. Louis (MO): Mosby Elsevier; 2008. p.1333-94.
- Rünger TM, DiGiovanna JJ, Kraemer KH. Hereditary disorders of genome instability and dna repair. In: Wolff KW, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leff ell DJ, editors. Fitzpatrick’s dermatology in general medicine. 7th ed. New York: McGraw-Hill. 2008. p.1311-25.
- Khatri ML, Bemghazil M, Shafi M, Machina A. Xeroderma pigmentosum in Libya. Int J Dermatol 1999; 38: 520-4.
- Bhutto AM, Shaikh A, Nonaka S. Incidence of xeroderma pigmentosum in Larkana, Pakistan: a 7-year study. Br J Dermatol 2005; 152: 545-51.
- Metin A, Bekerecioğlu M, Uğraş S, Delice İ. Van’da kseroderma pigmentozum. Türkderm 2000; 34: 45-8 (in Turkish).
- Kutluhan A, Bekerecioğlu M, Güney E, Metin A. Otorhinolaryngological aspects of Xeroderma pigmentosum. Auris Nasus Larynx 1999; 26: 457-66. 8. Gül Ü, Kılıç A, Gönül M, Külcü Çakmak S, Soylu S. Xeroderma pigmentosum: a Turkish case series. Int J Dermatol 2007; 46: 1125-8.
- Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum: cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 1987; 123: 241-50.
- Khan SG, Metin A, Gozukara E, Inui H, Shahlavi T, Muniz
- Medina V et al. Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: mutations result in reduced XPC mRNA levels that correlate with cancer risk. Hum Mol Genet 2004; 13: 343- 52.
- Gozukara EM, Khan SG, Metin A, Emmert S, Busch DB, Shahlavi T et al. A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: molecular genetic evidence for a common ancestor. J Invest Dermatol 2001; 117: 197-204.
- Dilek FH, Akpolat N, Metin A, Ugras S. Atypical fi broxanthoma of the skin and the lower lip in xeroderma pigmentosum. Br J Dermatol 2000; 143: 618-20.
- Green WH, Wang SQ, Cognetta AB. Total-body cutaneous
- examination, total-body photography, and dermoscopy in the care of a patient with xeroderma pigmentosum and multiple melanomas. Arch Dermatol 2009; 145: 910-5.
- Halpern J, Hopping B, Brostoff JM. Photosensitivity, corneal scarring and developmental delay. Xeroderma Pigmentosum in a tropical country. Cases J 2008; 1: 254.